These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32677853)

  • 21. Impact of Residual Mitral Regurgitation on Right Ventricular Systolic Function After Left Ventricular Assist Device Implantation.
    Ertugay S; Kemal HS; Kahraman U; Engin C; Nalbantgil S; Yagdi T; Ozbaran M
    Artif Organs; 2017 Jul; 41(7):622-627. PubMed ID: 27873344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy.
    Gupta S; Woldendorp K; Muthiah K; Robson D; Prichard R; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Dhital K; Granger E; Spratt P; Jansz P; Hayward CS
    Heart Lung Circ; 2014 Oct; 23(10):963-9. PubMed ID: 24973864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.
    Stulak JM; Tchantchaleishvili V; Haglund NA; Davis ME; Schirger JA; Cowger JA; Shah P; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 May; 34(5):718-23. PubMed ID: 25697807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of Atrial Fibrillation on Functional Tricuspid Regurgitation in Patients With HeartMate 3.
    Hayashi H; Naka Y; Sanchez J; Takayama H; Kurlansky P; Ning Y; Topkara VK; Yuzefpolskaya M; Colombo PC; Sayer GT; Uriel N; Takeda K
    J Am Heart Assoc; 2021 Feb; 10(3):e018334. PubMed ID: 33412902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes in patients who underwent a concomitant tricuspid valve procedure during left ventricular assist device implantation.
    Critsinelis A; Kurihara C; Kawabori M; Sugiura T; Loor G; Frazier OH; Morgan J
    J Card Surg; 2019 Dec; 34(12):1458-1464. PubMed ID: 31730728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residual mitral regurgitation in patients with left ventricular assist device support - An INTERMACS analysis.
    Jain R; Truby LK; Topkara VK
    J Heart Lung Transplant; 2022 Nov; 41(11):1638-1645. PubMed ID: 35379546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resolution of Mitral Regurgitation With Left Ventricular Assist Device Support.
    Goodwin M; Nemeh HW; Borgi J; Paone G; Morgan JA
    Ann Thorac Surg; 2017 Sep; 104(3):811-818. PubMed ID: 28527962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent mitral regurgitation after left ventricular assist device: a clinical conundrum.
    Cruz Rodriguez JB; Chatterjee A; Pamboukian SV; Tallaj JA; Joly J; Lenneman A; Aryal S; Hoopes CW; Acharya D; Rajapreyar I
    ESC Heart Fail; 2021 Apr; 8(2):1039-1046. PubMed ID: 33471962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of functional mitral regurgitation prior to left ventricular assist device implantation.
    Pausch J; Bhadra O; Mersmann J; Conradi L; Sill B; Barten MJ; Reichenspurner H; Bernhardt AM
    J Cardiothorac Surg; 2022 Feb; 17(1):24. PubMed ID: 35216595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors and clinical implications of residual mitral regurgitation following left ventricular assist device therapy.
    Sharma H; Liu B; Yuan M; Shakeel I; Morley-Smith A; Hatch A; Bradley J; Chue C; Myerson SG; Steeds RP; Lim S
    Open Heart; 2023 Jun; 10(1):. PubMed ID: 37316326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal cannula positioning of HeartMate 3 left ventricular assist device.
    Imamura T; Narang N; Nitta D; Fujino T; Nguyen A; Kim G; Raikhelkar J; Rodgers D; Ota T; Jeevanandam V; Sayer G; Uriel N
    Artif Organs; 2020 Dec; 44(12):e509-e519. PubMed ID: 32557769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant mitral valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: An INTERMACS database analysis.
    Robertson JO; Naftel DC; Myers SL; Tedford RJ; Joseph SM; Kirklin JK; Silvestry SC
    J Heart Lung Transplant; 2018 Jan; 37(1):79-88. PubMed ID: 29150326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Echocardiographic evaluation of percutaneous valve repair in patients with mitral regurgitation using the CARILLON system.
    Jerzykowska O; Kałmucki P; Wołoszyn M; Smuszkiewicz P; Firek L; Siminiak T
    Kardiol Pol; 2010 Jan; 68(1):57-63. PubMed ID: 20131189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures.
    Milano C; Pagani FD; Slaughter MS; Pham DT; Hathaway DR; Jacoski MV; Najarian KB; Aaronson KD;
    Circulation; 2014 Sep; 130(11 Suppl 1):S3-11. PubMed ID: 25200052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Residual Valve Disease on Survival After Implantation of Left Ventricular Assist Devices.
    Tanaka A; Kitahara H; Onsager D; Song T; Raikhelkar J; Kim G; Sarswat N; Sayer G; Uriel N; Jeevanandam V; Ota T
    Ann Thorac Surg; 2018 Dec; 106(6):1789-1796. PubMed ID: 30148976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of venopulmonary arterial extracorporeal life support as temporary right ventricular support after left ventricular assist implantation.
    Shehab S; Rao S; Macdonald P; Newton PJ; Spratt P; Jansz P; Hayward CS
    J Thorac Cardiovasc Surg; 2018 Dec; 156(6):2143-2152. PubMed ID: 30025607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation.
    Kitada S; Kato TS; Thomas SS; Conwell SD; Russo C; Di Tullio MR; Farr M; Schulze PC; Uriel N; Jorde UP; Takayama H; Naka Y; Homma S; Mancini DM
    J Heart Lung Transplant; 2013 Sep; 32(9):897-904. PubMed ID: 23850122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic Characteristics in Significant Symptomatic and Asymptomatic Primary Mitral Valve Regurgitation at Rest and During Exercise.
    Bakkestrøm R; Banke A; Christensen NL; Pecini R; Irmukhamedov A; Andersen M; Borlaug BA; Møller JE
    Circ Cardiovasc Imaging; 2018 Feb; 11(2):e007171. PubMed ID: 29449412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of severe mitral regurgitation on postoperative outcome after durable left-ventricular assist device implantation.
    Zubarevich A; Szczechowicz M; Arjomandi Rad A; Osswald A; Papathanasiou M; Luedike P; Koch A; Pizanis N; Kamler M; Schmack B; Ruhparwar A; Weymann A
    Artif Organs; 2022 May; 46(5):953-963. PubMed ID: 34931335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin of the left coronary artery from the pulmonary artery?
    Brown JW; Ruzmetov M; Parent JJ; Rodefeld MD; Turrentine MW
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):743-8. PubMed ID: 18805280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.